Home »
Academic Articles »
C »
Data supporting the angiotensin II activates MEL18 to deSUMOylate HSF2 for hypertension-related heart failure
Data supporting the angiotensin II activates MEL18 to deSUMOylate HSF2 for hypertension-related heart failure
Chih-Yang Huang
(Translation Research Core, China Medical University Hospital, China Medical University, Taichung, Taiwan)
Chia-Hua Kuo
(Department of Sports Sciences, University of Taipei, Taipei, Taiwan)
Pei-Ying Pai
(Division of Cardiology, China Medical University Hospital, Taichung, Taiwan)
Tsung-Jung Ho
(School of Chinese Medicine, China Medical University, Taichung, Taiwan; Chinese Medicine Department, China Medical University Beigang Hospital, Taiwan)
Yueh-Min Lin
(Department of pathology, Changhua Christian Hospital, Changhua, Taiwan; Department of Medical Technology, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli, Taiwan)
Ray-Jade Chen
(Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan)
Fuu-Jen Tsai
(School of Chinese Medicine, China Medical University, Taichung, Taiwan)
V. Vijaya Padma
(Department of Biotechnology, Bharathiar University, Coimbatore 641046, India)
Wei-Wen Kuo
(Department of Biological Science and Technology, China Medical University, Taichung, Taiwan)
Chih-Yang Huang
(School of Chinese Medicine, China Medical University, Taichung, Taiwan; Graduate Institute of Basic Medical Science, China Medical University, Taichung, Taiwan; Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan; Corresponding author at: Graduate Institute of Basic Medical Science, China Medical University, Taichung 40402, Taiwan.)
Journal: Data in Brief
•
• Elsevier
• ISSN: 2352-3409
Abstract
In association with the published article “Inhibition of HSF2 SUMOylation via MEL18 upregulates IGF-IIR and leads to hypertension-induced cardiac hypertrophy” (Huang et al., 2017) [1], this data article contains information about deSUMOylation of HSF2 on lysine 82 on angiotensin II (ANG II) -induced cardiac hypertrophy, which is mediated by MEL18. Isolated adult human whole heart tissue showed MEL18-mediated HSF2-IGF-IIR pathway is upregulated in hypertension human heart, compared to health human heart.
Chih-Yang Huang, Chia-Hua Kuo, Pei-Ying Pai, et al. (2018). "Data supporting the angiotensin II activates MEL18 to deSUMOylate HSF2 for hypertension-related heart failure". Data in Brief. https://doi.org/10.1016/j.dib.2017.11.040